News
Summit Therapeutics (SMMT) stock gains as AstraZeneca (AZN) is said to eye its lung cancer drug ivonescimab, a potential ...
Revolution Medicines Inc. (NASDAQ:RVMD) is one of the best high short interest stocks with huge upside potential. On June 30, ...
As a result, Britain say the strongest June for new car sales since 2019, with 191,316 cars registered, according to the ...
Tesla's new car sales in Britain rose year-on-year in June amid a broader recovery in the electric-vehicle market, data ...
4d
Zacks Investment Research on MSNWall Street Analysts Believe Summit Therapeutics (SMMT) Could Rally 63.02%: Here's is How to TradeShares of Summit Therapeutics PLC (SMMT) have gained 2.8% over the past four weeks to close the last trading session at $21.2 ...
Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the 30 stocks expected to beat the market by 20 percentage points this ...
Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...
5d
GlobalData on MSNUK vehicle production constraints affect May output: SMMTUK vehicle production continues to face constraints, with figures from the Society of Motor Manufacturers and Traders (SMMT) ...
Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the 30 stocks expected to beat the market by 20 percentage points this year. Analysts at H.C.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results